Meyonex Pharmaceuticals Limited, a active public limited company, was established on 17 January 2015 in Palghar, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74120MH2015PLC261024. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹14.00 Cr.
Formerly known as Aveo Pharmaceuticals Limited. It upholds a compliant status. Employing 48 professional, Its leadership includes Arvind Awadhnath Sharma (Director), Vinod Kumar Sharma (Director), Shivani Sharma (Additional Director). Past directors included Varun Sharma, Arvind Kumar Sharma, Bijoy Deb. It holds ₹21.02 Cr open charges and ₹2.50 M settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No C - 13 Midc Tarapur Palghar, Palghar, Maharashtra, 401506.
U74120MH2015PLC261024
261024
17 January 2015
₹20.00 Cr
₹14.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Meyonex Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Awadhnath Sharma | Director | 17 Jan 2015 | Current |
| Vinod Kumar Sharma | Director | 28 Mar 2018 | Current |
| Shivani Sharma | Additional Director | 04 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Mar 2025 | Past |
| Pramod Abcsdd | Director | 13 Aug 2020 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aveo Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 73.16% increase. The company also saw a substantial improvement in profitability, with a 94.54% increase in profit. The company's net worth Soared by an impressive increase of 75.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Meyonex Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹210,150,000.00
₹2,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2023 | Others | ₹2.41 Cr | Open |
| 26 Sep 2023 | Others | ₹11.00 Cr | Open |
| 26 Sep 2023 | Others | ₹6.11 Cr | Open |
| 08 Feb 2023 | Others | ₹1.50 Cr | Open |
| 20 Apr 2021 | Hdfc Bank Limited | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Meyonex Pharmaceuticals has a workforce of 48 employees as of Jul 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Meyonex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meyonex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 11.00 Cr registered on 26 Sep 2023 with Charge ID 100815040 was modified on 31 Jan 2025. was recorded as a recent event.
The activity Shivani Sharma was appointed as a Additional Director was appointed as a Additional Director on 04 Oct 2024 & has been associated with this company since 1 year 1 month . was completed.
Meyonex Pharmaceuticals Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Others of Rs. 6.11 Cr registered on 26 Sep 2023 with Charge ID 100815031 was modified on 29 May 2024. was documented.
Progress on A charge registered on 20 Apr 2021 via Charge ID 100445895 with Hdfc Bank Limited was fully satisfied on 31 Mar 2024. was documented.
Progress on Meyonex Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The CIN of Meyonex Pharmaceuticals Limited is U74120MH2015PLC261024.
Meyonex Pharmaceuticals Limited is headquartered at Plot No C - 13 Midc Tarapur Palghar, Palghar, Maharashtra, 401506.
Meyonex Pharmaceuticals Limited was incorporated on 17 January 2015.
The current directors of Meyonex Pharmaceuticals Limited are
The primary industry of Meyonex Pharmaceuticals Limited is Manufacturing.
Meyonex Pharmaceuticals Limited is unlisted.
The authorized capital of Meyonex Pharmaceuticals Limited is ₹20.00 Cr, and the paid-up capital is ₹14.00 Cr.
The compliance status of Meyonex Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX